Surf, aF limiting comments argues that he is pr
Post# of 153778
(Total Views: 774)
Posted On: 09/02/2020 8:07:51 PM
Surf,
aF limiting comments argues that he is preaching to the converted. A fervent but ever shrinking group of supporters who diminish in importance over time.
The message of leronlimab continues to spread. Dr. Yo, multiple media channels, our own Dawson.
I was ready to retire in May after reading Dr. Oatteron’s manuscript,, but truly am not worried.
Frustrated? Of course!
I stand by my statements that leronlimab is a transformative molecule. I know so many afflicted with the often bizarre manifestations of chronic inflammatory processes (post -Lyme, MS, ALS), as well as cancers and HIV, that I am incensed that the glacial regulatory processes deny them relief.
I remain exultant that the answer has been found. We are now weeks and months from salvation for many millions, not years and decades.
I struggle to find a way to care any less about the bashers and liars.
Leronlimab WILL transform medicine. Not soon enough, but soon.
Much better days lie ahead.
aF limiting comments argues that he is preaching to the converted. A fervent but ever shrinking group of supporters who diminish in importance over time.
The message of leronlimab continues to spread. Dr. Yo, multiple media channels, our own Dawson.
I was ready to retire in May after reading Dr. Oatteron’s manuscript,, but truly am not worried.
Frustrated? Of course!
I stand by my statements that leronlimab is a transformative molecule. I know so many afflicted with the often bizarre manifestations of chronic inflammatory processes (post -Lyme, MS, ALS), as well as cancers and HIV, that I am incensed that the glacial regulatory processes deny them relief.
I remain exultant that the answer has been found. We are now weeks and months from salvation for many millions, not years and decades.
I struggle to find a way to care any less about the bashers and liars.
Leronlimab WILL transform medicine. Not soon enough, but soon.
Much better days lie ahead.
(18)
(0)